u/Boring_Cartoonist952

Hey everyone,

We recently had a meeting with a VC (follow up after our initial pitch) and we realised that the questions from the GP were quite tough when it came to our commercial strategy.

They basically asked “What will be your main source of revenue” and we basically fumbled it and focused on the wrong thing and we did not have a slick pitch there. We still think our initial commercial revenue generators are fair but it didn’t flow well and looked cluttered.

That said, we now had to rethink our commercial strategy for our next pitch but we are simplifying it down to a ridiculous amount so that the story flows well.

The also means our company starts to look quite different to what we originally started pitching it as. That is what is our worry.

Now is it normal to “pivot” our commercial strategy to make it more VC friendly after a VC meeting or is it better to stick to our original pitch?

Hey everyone,

I am super interested in the pharmaceutical industry and so when I was seeing some of my patients taking drugs in other developed countries (think Western Europe) which are not available in US, I kept wondering why. Those drugs are similar in efficacy to say the drugs in the US.

Naturally, a lot of the regulatory authorities in Western Europe or Europe (I assume) are congruent in thought to the American FDA, as well as the standards of care between say Europe and US are not too dissimilar.

This naturally makes me want to know why there is this discrepancy between highly advanced countries?